Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Problems mounting for Ryanair, the can of worms has well and truly been opened. Who feels safe flying in a Boeing max now?
https://news.sky.com/video/ryanair-boss-says-passengers-are-safe-despite-boeing-blowout-issues-13049824
Alright Captain Mainwaring calm down. It's just following the FTSE movements.
If you're not comfortable with stock market movements, I suggest you put your capital into a cash ISA
It was an ok update. Renewal rate drop was disappointing, but nice new contract win, albeit small.
Pipeline is encouraging but the key is converting that into hard sales. If that's achieved, this will go well in 2024/5. Commercialisation is key.
Https://www.bbc.co.uk/news/business-67994140
Things not looking good for Ryanair. Tied in with Boeing who are in a mess, openly admitting that deliver delays are hindering their capacity and saying Ryanair don’t have confidence in Boeing’s quality control measures!
Very encouraging business update, a lot of exciting pipeline projects and cash burn better than expected.
No near term cash concerns and commercial discussions ongoing. What’s more is the ETX platform looks to have now been proven. 2024 could be a transformative year if those major commercial deals land as expected
Good write up and interview. Worth a read
https://www.proactiveinvestors.co.uk/companies/news/1038104/c4xd-a-biotechnology-pioneer-in-immuno-inflammation-1038104.html
i did love the positive spin put by epstein on the failed raise.
they're **** out of luck, they've thrown their last dice and the numbers haven't come up. now they're on the home straight to administration. 2024 mos rip
As posted on 9th Jan by myself:
So how much of the £300k do you think will be raised? Place your bets now..............
I think they'll struggle to raise half that with the SP hovering below.
Given the lack of alternative opinions, which was disappointing, I will take the prize of the correct answer :)
Thanks, was just about to look up!
So probably no immediate impact for Wizz. We await Q3 results with interest
So how much of the £300k do you think will be raised? Place your bets now..............
I think they'll struggle to raise half that with the SP hovering below.
I remember when Nigel Burton reassured me at the last fund raise, that this was to get them to break even point and no further fund raises would be required. I'm glad I didn't invest further on that basis
My question remains, which European competitors have the 737 MAX? I can do some digging if others don’t know. I think Norwegian do.
This is a major issue with the model now and I can’t see it being approved to fly again anytime soon so this potentially creates a huge opportunity for Wizz to capitalise. There will be a shortage of aircraft now for sure into the summer. The US market will particularly be hit
Given this is a Tiziana bulletin board, I would imagine that most people who visit this page are interested in its news.
As for Accustem, I suggest you email the board if you would like to find out further
New RNS update:
Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough neuro-immunomodulation therapies, today announced positive findings have been seen in a total of six out of eight Intermediate Size Patient Population Expanded Access (EA) patients. These patients have shown improvements in fatigue scores measured by the Modified Fatigue Impact Scale (MFIS). PET scan findings showing a reduction in microglial activation was also seen in the six patients with MFIS score improvement at the three-month evaluation period. PET scan findings for two additional EA patients (10 total) are planned to be available in late January.
Tarun Singhal, M.B.B.S., M.D., Director of PET Imaging Program in Neurologic Diseases at Brigham and Women’s Hospital, a founding member of Mass General Brigham Healthcare System, and Associate Professor of Neurology at Harvard Medical School, commented, “Upon review of the baseline and three-month [F-18] PBR06 PET scans of the two new na-SPMS EA patients, a qualitative reduction in microglial activity was seen in one of two new patients. When combined with my assessment of the first six EA patients at three-months, a total of six out of the eight suggested a reduction in qualitative microglial PET signal. These findings are promising from an imaging standpoint and further studies are needed to confirm them using additional quantitative approaches.”
“The EA patient having a qualitative improvement in their PET scan also improved in their Modified Fatigue Impact Scale,” stated Dr. Tanuja Chitnis, M.D., Principal Investigator and Professor of Neurology at Harvard Medical School and senior neurologist at Brigham and Women’s Hospital. “Six out of the eight na-SPMS EA patients studied so far have seen measurable clinical improvement in their fatigue. I am excited to lead the effort to replicate these findings in the ongoing Phase 2 dose-ranging, randomized, placebo-controlled clinical trial.”
Gabriele Cerrone, Chairman, acting CEO and founder of Tiziana Life Sciences noted “We’ve seen continued clinical and qualitative PET scan improvement over time in patients with na-SPMS where intranasal foralumab targets inflammation in the brain. It is my expectation that we will rapidly progress our ongoing Phase 2 trial of intranasal foralumab, given the encouraging results seen so far under the EA IND."
https://ir.tizianalifesciences.com/news-releases/news-release-details/tiziana-life-sciences-announces-updated-clinical-and-pet-scan
I’m wondering if any of Wizz competitors have the 737 max? I know Ryanair have a lot of Boeing aircraft but not sure on the models
I disagree, 4 weeks is long enough to raise capital, they could have been working on this in the background. But unless they have some commercial deal lined up, it's unlikely to succeed.
This is as likely to go into administration as it is to continue, if not more likely. Place your bets
Thanks for sharing.
I concur that this rise is more than just reassurance on funding requirements - it is further validation of the tech, and an important value inflection point. The 3 days of consecutive strong SP rises on heavy trading demonstate that.
With a Sanofi milestone payment imminent and further deals in the pipeline, I expect a big 2024. This was above 40p a couple of years ago. I expect it to rise significantly above that
We believe the risk reduction could be substantial with combination therapy.”